Concepedia

Dale E. Mais

DE

80

Publications

4.3K

Citations

35

H-Index

1974

Active since

Affiliations

Ligand Pharmaceuticals (United States)(Current)

Medical University of South Carolina

Eli Lilly (United States)

Indiana University Bloomington

Dale E. Mais is an author at Ligand Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1974–2016

80

Publications

80

Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids

Marcus F. Boehm, Lin Zhang, Beth Ann Badea et al. · Journal of Medicinal Chemistry · 1994 · 373 citations · Full text

, , +12

The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.

D X Wen, Yifeng Xu, Dale E. Mais et al. · Molecular and Cellular Biology · 1994 · 341 citations · Full text

, , +19

Design and Synthesis of Potent Retinoid X Receptor Selective Ligands That Induce Apoptosis in Leukemia Cells

Marcus F. Boehm, Michael McClurg, E. Berger et al. · Journal of Medicinal Chemistry · 1995 · 338 citations · Full text

Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR.

Sutisak Kitareewan, Leo T. Burka, K B Tomer et al. · Molecular Biology of the Cell · 1996 · 201 citations

, , +18

Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.

Dale E. Mais, D L Saussy, Amer Chaikhouni et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 153 citations

Rows per page

1–5 of 80